Shoppers of data and healthcare leaders alike are turning to real-world evidence (RWE) oncology platforms as cancer care goes data-driven; clinicians, pharma and payers worldwide are using RWE to speed approvals, personalise treatments and back reimbursement decisions, making these solutions one of the fastest-growing segments in health tech. Essential Takeaways…

Shoppers and clinicians alike are paying attention as Sera Prognostics pushes its PreTRM prenatal risk test into wider use; the company says focused awareness, payer talks, and targeted partner programmes could drive adoption , and its cash runway now stretches into 2029, giving it time to prove the case. Essential…

Shoppers and investors are watching the anti-hyperglycemic agents market as diabetes care shifts from simple glucose control to cardiorenal protection and weight management; rising type 2 diabetes, new oral GLP-1s, biosimilars and AI-driven tools are reshaping demand and value across North America, Europe and Asia Pacific. Essential Takeaways Market size:…

Shoppers , and investors , are watching as BillionToOne posts a blockbuster quarter: Q1 revenue jumped 84%, driven by booming prenatal testing and a newly launched non‑invasive confirmation assay that could shift how high‑risk pregnancies are managed. Here’s what that growth looks like, why it matters, and what to watch…

Shoppers in the clinic might soon have a new tool: researchers are developing a blood test that predicts how illnesses will unfold and whether treatments will work, potentially helping doctors triage patients faster and deliver more personalised care. Essential Takeaways What it measures: detects RNA markers in whole blood that…

Shoppers are turning to smarter lab kit as drug discovery labs push for speed, consistency and scale; the latest automation tech , from AI-enabled genomics tools to robotic liquid handlers , promises faster screens, fewer errors and a clearer path from experiment to insight. Essential Takeaways Market momentum: Lab automation…

Watchdogs are deploying smarter tools , FDA staff now have Elsa 4.0 tied to a single data platform, speeding searches and cutting manual busywork so scientists can focus on safety and approvals. This matters for patients, companies and clinicians who want faster, clearer regulatory decisions. Essential Takeaways Faster search: Elsa…

Shoppers and clinicians alike are tuning in to the human voice , researchers say vocal biomarkers can screen for cognitive, neurological and mental-health conditions quickly and cheaply, using just a short recording; that matters because earlier detection often means better outcomes, lower costs and more time for families to plan.…

Shippers and fleet managers are leaning into AI agents to cut paperwork, reduce downtime and sharpen safety decisions; Lytx’s new agent suite for its LytxOne platform promises tangible gains for operations teams, with explainable recommendations and human control that matter on the road. Essential Takeaways Purpose-built agents: Lytx’s AI Agents…

Shoppers of legal tech are switching on to smarter fraud defences , firms, insurers and in-house teams are tuning into Fraud Rely, a new anti-fraud intelligence platform launched by law firm Weightmans in collaboration with global analytics leader Verisk, and it could reshape how organisations meet the new failure-to-prevent-fraud rules.…

Shoppers are turning to smarter tools as finance teams test Anthropic’s Claude Financial Services Solutions, a package of 10 AI agents and integrations that promise to shave days off tasks like KYC, GL reconciliation and pitch-book prep, here’s what it does, who’s trying it and how to evaluate it. Essential…

Shoppers are trying conversational insurance , MyChoice has launched Canada’s first auto and life insurance shopping app inside ChatGPT, letting Canadians chat their way to tailored quotes and then finish a purchase on MyChoice’s platform. It matters because more customers now expect quick, conversational entry points before speaking to brokers.…